The Indian Pharmaceutical Alliance (IPA) on Monday appointed Glenn Saldanha as president.
Saldanha is chairman & managing director of Glenmark Pharmaceuticals. IPA also appointed Panacea Biotec Joint Managing Director Rajesh Jain as vice-president.
The IPA, initially formed by eight national companies in 1999, now has 20 research-based national pharmaceutical firms in its fold.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)